Lauxera Capital Partners has acquired a majority stake in Matrix Requirements, a provider of medical technology quality management software.
The software company helps medical device companies achieve quality and regulatory compliance in a world where the lines between medical devices and software are blurring. Matrix Requirements helps medical device companies develop complex products, often with significant software functionality. In addition to more traditional medtech customers, Matrix’s product portfolio is designed to serve the rapidly growing “software as a medical device” field encompassing digital therapies, connected devices and technologies leveraging machine learning. /artificial intelligence.
This is the seventh investment made by Lauxera Growth I, a growth-oriented buyout fund dedicated to investing in European healthcare technologies.
Founded in 2014 by Wolfgang Huber (former VP R&D at Advanced Medical Diagnostics and co-founder of NeoMed Software) and Yves Berquin (former program manager at Advanced Medical Diagnostics and CTO at SleepOnWeb), Matrix Requirements has become a quality leader in the medtech space management system software with two highly differentiated solutions:
- MatrixALM, flexible software for managing the technical files of medical devices in order to accelerate regulatory approvals (CE marking, FDA approval, etc.) and reduce the risk of non-compliance
- MatrixQMS, a quality management system solution enabling medical technology companies to develop and maintain their own quality systems reflecting the specific needs of their products in accordance with ISO and FDA standards.
To date, these solutions have been adopted by more than 180 medtech companies around the world.
Wolfgang Huber and Yves Berquin, co-founders of Matrix Requirements, said, “We are delighted to partner with Lauxera to accelerate the development of Matrix Requirements and our products. We share the vision of continuing to offer the best solutions to make Matrix Requirements a world leader in its industry. This transaction gives the company the means to significantly accelerate its growth by adding to the team of which we are very proud. Lauxera’s entrepreneurial culture, skills and experience make it an ideal partner. We are delighted with this new stage in our development.
Samuel Levy, Founding Partner of Lauxera Capital Partners, added, “Yves and Wolfgang have built outstanding medtech quality management system products that delight customers and accelerate time-to-market for life-saving medical devices. The medtech eQMS software market exceeds $2.5 billion and is We are excited to work hand-in-hand with Matrix’s leadership team to strengthen the company’s business engine and enable our customers to spend rigorous audits without non-conformities.